
Adapt Pharmaceutical Private Limited
About Adapt Pharmaceutical Private Limited
Data last updated:
Adapt Pharmaceutical Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 February 2022.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U52399UP2022PTC160165.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Jitendra Kumar Boudh and Ajeet Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A2/280 Sector F Extn Lda Colony, Lucknow, Uttar Pradesh, India – 226012.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.85 Lakh, a growth of 28% compared to the previous year. For the same year it recorded a net loss of ₹1.11 Lakh (net margin -12.6%) and EBITDA of -₹1.1 Lakh (EBITDA margin -12.4%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressA2/280 Sector F Extn Lda Colony, Lucknow, Uttar Pradesh, India – 226012
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Adapt Pharmaceutical Private Limited
The main business activity of Adapt Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Adapt Pharmaceutical Private Limited FY 2025 filings available
Adapt Pharmaceutical Private Limited reported revenue of ₹8.85 Lakh (up 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Adapt Pharmaceutical Private Limited
Revenue rose 28% in the latest year. EBITDA fell 183% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Adapt Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.1 Lakh | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.11 Lakh | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Adapt Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -12.4% | •••• | •••• | •••• |
| Net Profit Margin | -12.6% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Adapt Pharmaceutical are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Adapt Pharmaceutical Private Limited
Adapt Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Revenue, net profit, margin and growth of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ropoz Lifesciences Private Limited | •••• | •••• | •••• | •••• | - | Ambala City, Haryana, India |
| Vahitra Unnati Private Limited | •••• | •••• | •••• | •••• | - | Uttarakhand, India |
| Globetech Systems Integrators Private Limited | •••• | •••• | •••• | •••• | - | Mumbai, Maharashtra, India |
| Mectron Solutions Private Limited | •••• | •••• | •••• | •••• | - | Pune, Maharashtra, India |
| Vianks Computers Private Limited | •••• | •••• | •••• | •••• | - | Miraroad, Maharashtra, India |
| Adapt Pharmaceutical Private Limited this company | •••• | •••• | •••• | •••• | - | Lucknow, Uttar Pradesh, India |
| Ayilam Technologies Private Limited | •••• | •••• | •••• | •••• | - | Chennai, Tamil Nadu, India |
| Naturafine India Private Limited | •••• | •••• | •••• | •••• | - | Mathura, Uttar Pradesh, India |
| Christy Agro Tech Private Limited | •••• | •••• | •••• | •••• | - | Tiruchengode Tk, Tamil Nadu, India |
| Zebron Trading and Shopping Private Limited | •••• | •••• | •••• | •••• | - | Kalyani, West Bengal, India |
| Ezidrop Private Limited | •••• | •••• | •••• | •••• | - | Irinjalakuda, Kerala, India |
Peers are the five companies nearest above and the five nearest below Adapt Pharmaceutical by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Revenue, net profit, margin and growth of each peer are in the company report.
Board of Directors of Adapt Pharmaceutical Private Limited
Adapt Pharmaceutical has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jitendra Kumar Boudh | Director | 28 Feb 2022 | 4 Years 7 Months | Current |
| Ajeet Kumar | Director | 28 Feb 2022 | 4 Years 7 Months | Current |
| Shubham Bharti | Director | 15 Jan 2025 | 1 Years 8 Months | Current |
Charges & Borrowings of Adapt Pharmaceutical Private Limited
Adapt Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Adapt Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Adapt Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Adapt Pharmaceutical Private Limited
Adapt Pharmaceutical Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Shubham Bharti was appointed as Director on 15 Jan 2025.
Credit Ratings, Litigation & Regulatory Alerts for Adapt Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Adapt Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Adapt Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Adapt Pharmaceutical Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Adapt Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Adapt Pharmaceutical Private Limited
Adapt Pharmaceutical is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 February 2022 (4+ years old) and is registered under CIN U52399UP2022PTC160165.
Adapt Pharmaceutical reported revenue of ₹8.85 Lakh for FY 2025 (up 28% YoY).
Adapt Pharmaceutical has 3 current directors:
- Jitendra Kumar Boudh - Director
- Ajeet Kumar - Director
- Shubham Bharti - Director
Adapt Pharmaceutical reported a net loss of ₹1.11 Lakh (net margin -12.6%) and EBITDA of -₹1.1 Lakh (EBITDA margin -12.4%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Adapt Pharmaceutical is U52399UP2022PTC160165. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adapt Pharmaceutical was incorporated on 28 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Adapt Pharmaceutical by revenue are Ropoz Lifesciences Private Limited, Vahitra Unnati Private Limited, Globetech Systems Integrators Private Limited, Mectron Solutions Private Limited, Vianks Computers Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Shubham Bharti was appointed as Director on 15 Jan 2025. Ajeet Kumar was appointed as Director on 28 Feb 2022. Jitendra Kumar Boudh was appointed as Director on 28 Feb 2022.
The registered office of Adapt Pharmaceutical is at A2280 Sector F Extn Lda Colony, Lucknow, Uttar Pradesh, India – 226012.
Adapt Pharmaceutical has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Adapt Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.